You searched for metabolic diseases - Page 56 of 62

News and Trends 25 Jul 2023

Roche and Alnylam to work on RNAi therapeutic to treat hypertension

…transform the landscape for patients with severe cardiovascular diseases,” said Yvonne Greenstreet, chief executive officer of Alnylam. “With this collaboration, we now can develop zilebesiran in a more robust way,…

July 25, 2023 - 5 minutesmins - By Jim Cornall

In Depth 23 May 2022

The coming of age of European synthetic biology

…human consumption. “Investors see the promise behind synbio being able to produce many molecules in a much more sustainable and efficient way. With synbio, any metabolic pathway is theoretically accessible…

May 23, 2022 - 8 minutesmins - By Helen Albert

News and Trends 23 Jan 2018

NASH Leader goes Pediatric with Clinical Trial Launch in US

The FDA has cleared Genfit to kick off clinical trials to see if its NASH drug, elafibranor, can also help children. Genfit develops diagnostic and therapeutic tools for metabolic and…

January 23, 2018 - 2 minutesmins - By Alex Dale

In Depth 4 Mar 2025

The biggest biotech funding rounds in February 2025

…total. And, thanks to Abcuro’s $200 million financing round, the autoimmune diseases subsector brought in the second-largest amount of funding last month, despite there only being one round. Public biotech…

March 4, 2025 - 4 minutesmins - By Willow Shah-Neville

Best in Biotech 4 Jul 2025

14 biotech companies to know in the Boston area in 2025

…into protein, ideal for diseases caused by mutations in large genes that are hard to edit at the DNA level. Its lead candidate, ACDN‑01, is the first-ever clinical-stage RNA exon…

July 4, 2025 - 15 minutesmins - By Jules Adam

In Depth 11 Aug 2022

Biosecurity is synthetic biology’s most crucial ally

…at Ginkgo Bioworks, HydGene Renewables and Eden Brew, the community is working on solutions for such eventualities. “Physical containment, integrated kill switches and metabolic dependencies, for instance, provide technical control…

August 11, 2022 - 6 minutesmins - By Kostas Vavitsas

In Depth 4 Jul 2022

The COVID-19 pandemic has driven RNA therapeutics into the mainstream

As messenger RNA vaccines save lives around the world, and RNA interference drugs are greenlit for rare diseases, the field of RNA therapeutics is now moving faster than ever before….

July 4, 2022 - 8 minutesmins - By Helen Albert

Persephone Bisociences Microbiome health

Startup Scout 28 Oct 2022

Persephone Biosciences studies the microbiome in baby poop

…for the treatment of the metabolic disorder hyperoxaluria. And in March 2022, the U.K. firm Microbiotica bagged £50 million ($67 million) in a Series B round to finance its own…

October 28, 2022 - 6 minutesmins - By Jonathan Smith

News and Trends 25 Jul 2022

Drug that could be the first and only in Europe to treat rare brain condition recommended for marketing authorization

…company that focuses on genetic diseases and cancers, and Sentynl Therapeutics, Inc., a U.S.-based biopharmaceutical company that produces therapies for people living with rare diseases made the announcement today (July…

July 25, 2022 - 4 minutesmins - By Liza Laws

News and Trends 5 Oct 2017

Synbio adds Softness: Robots of the Future will be Squishy

…exist in nature, which therefore has a nice synergy with soft robotics. For example, genetic and metabolic circuits, two well-progressed fields of synthetic biology, could be implemented within the body…

October 5, 2017 - 5 minutesmins - By External Contributor

CatalYm’s monoclonal antibody visugromab bags $150M

News and Trends 16 Jul 2024

German biotech raises $150M on its way to tackle cancer therapy resistance

…patients through improvement of quality of life and body weight benefit. GDF-15 is not only a central regulator of immune resistance but also has a metabolic function. For instance, it…

July 16, 2024 - 9 minutesmins - By Jules Adam

Altheia Science gene therapy autoimmune disease

News and Trends 8 Apr 2020

Evotec Makes Move into Gene Therapy with Takeda Deal

…on gene therapy techniques, has expertise in virology and blood disorders, as well as metabolic and muscle diseases. Gene therapy has undergone a revolution in recent years and has changed…

April 8, 2020 - 3 minutesmins - By Helen Albert

Knowledge hub

Categories

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

Roche and Alnylam to work on RNAi therapeutic to treat hypertension

The coming of age of European synthetic biology

NASH Leader goes Pediatric with Clinical Trial Launch in US

The biggest biotech funding rounds in February 2025

14 biotech companies to know in the Boston area in 2025

Biosecurity is synthetic biology’s most crucial ally

The COVID-19 pandemic has driven RNA therapeutics into the mainstream

Persephone Biosciences studies the microbiome in baby poop

Drug that could be the first and only in Europe to treat rare brain condition recommended for marketing authorization

Synbio adds Softness: Robots of the Future will be Squishy

German biotech raises $150M on its way to tackle cancer therapy resistance

Evotec Makes Move into Gene Therapy with Takeda Deal

Subscribe to our newsletter to get the latest biotech news!

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!